Science – REPRODUCTIVE RIGHTS ALERTS

15 Oct

The quest to make babies with lab-grown eggs and sperm

CoreyLatest NewsFertility, Healthcare, Reproductive rights, Science

Sex cells made from scratch could revolutionize human reproduction. But researchers are struggling to translate promising results in mice into benefits for humans.

02 May

The Women’s Health Initiative has shaped women’s health for over 30 years, but its future is uncertain

DoryLatest NewsHealthcare, NIH, Reproductive rights, Science, Trump, United States, Women's Health

Women make up more than 50% of the population, yet before the 1990s they were largely excluded from health and medical research studies. To try to help correct this imbalance, in 1991 the National Institutes of Health launched a massive, long-term study called the Women’s Health Initiative, which is still running today. It is the largest, longest and most comprehensive study on women’s health ever conducted in the U.S. It also is one of the most productive studies in history, with more than 2,400 published scientific papers in leading medical journals.

09 Apr

Science integrity in sexual and reproductive health and rights

ChaseLatest NewsHealthcare, Reproductive rights, Science, Webinar

Navigating truth in a changing world Join us on April 9th for a crucial conversation on the growing impact of misinformation in sexual and reproductive health and rights (SRHR). This webinar will provide examples of how disinformation has shaped policy and outcomes, explore the challenges faced by the scientific and advocacy communities, and spark a collective discussion on strategies to uphold truth and evidence-based decision-making in SRHR.

17 Mar

The Root Causes of the Innovation Gap in Women’s Health

RandyLatest NewsHealthcare, Reproductive rights, Science, United States, Women's Health

Dr. Dina Radenkovic, CEO of Gameto, discusses the company's pioneering use of induced pluripotent stem cell (iPSC) technology in fertility treatments, particularly addressing ovarian aging. Its lead product, Fertilo, is an iPSC-derived ovarian support cell line in phase III clinical trials in the US with FDA clearance, and commercial availability in markets like Australia and Latin America. The company faces challenges including the scarcity of human eggs and regulatory hurdles. Radenkovic also highlights the need for better models to study female-specific conditions and the importance of political advocacy and funding to drive innovation in women's health.

30 Sep

IVF Restrictions, Demise of Roe v. Wade Could Endanger Women’s Health Research

BarbraLatest NewsIVF, Post-Dobbs, Reproductive rights, Science

Women are already underrepresented in clinical trials; the new abortion and IVF laws could make it worse.